Celldex Reports Second Quarter 2012 Financial Results
07:00 EDT 10 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Celldex
Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results
for the second quarter ended June 30, 2012. Celldex reported a net loss
of $13.8 million, or $0.23 per share, for the second quarter of 2012
compa...
Other Sources for this Article
Celldex Therapeutics, Inc.
Sarah Cavanaugh, 781-433-3161
Vice
President of IR & Corp Comm
scavanaugh@celldextherapeutics.com
or
Avery
W. Catlin, 781-433-0771
Chief Financial Officer
IR@celldextherapeutics.com
or
For
Media:
BMC Communications
Brad Miles, 646-513-3125
bmiles@bmccommunications.com
More From BioPortfolio on "Celldex Reports Second Quarter 2012 Financial Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
